Navigation Links
BioMarin to Present at the Oppenheimer Healthcare Conference
Date:10/27/2009

NOVATO, Calif., Oct. 27 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Hank Fuchs, M.D., Chief Medical Officer of BioMarin, will present a company update at the Oppenheimer Healthcare Conference in New York City on Tuesday, November 3, 2009 at 1:35 p.m. ET.

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.BMRN.com. A replay of the call will be archived on the site for one week following the call.

About BioMarin

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is in Phase II clinical development for the treatment of PKU and GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase I/II clinical development for the treatment of MPS IVA. For additional information, please visit www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.

BioMarin®, Naglazyme® and Kuvan® are registered trademarks of BioMarin
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. BioMarin Acquires Huxley Pharmaceuticals, Inc.
2. BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
3. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
4. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
5. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
6. BioMarin Announces FDA Approval for Kuvan
7. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
8. Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society
9. Phase 2 Data From Oral NKTR-118 Presented at American College of Gastroenterology in San Diego
10. STAAR Surgical to Present at the 20th Annual Oppenheimer Healthcare Conference in New York
11. Regeneron Announces Presentation at the 18th Annual Credit Suisse Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... NORTHBROOK, Ill. , July 22, 2014 /PRNewswire/ ... has announced that the U.S. Food and Drug ... standards as consensus standards for medical devices incorporating ... UL 2054 - Standard for Household and Commercial ... Batteries (Cells). Consensus standards are ...
(Date:7/22/2014)... WASHINGTON, New York , July ... Neue Partnerschaft für umfassenden Schutz ... Medikamenteneinwirkungen in Österreich    ... Anbieter von geschlossenen Transfersystemen (Closed System Transfer Devices, CSTDs) ... Medikus , einen Vertriebshändler und Hersteller ...
(Date:7/21/2014)... July 21, 2014 Thoratec Corporation (NASDAQ: ... circulatory support therapies to save, support and restore failing ... results for the second quarter of fiscal year 2014 ... hold a conference call to discuss its financial results ... 1:30 p.m., Pacific Daylight Time (4:30 p.m., Eastern Daylight ...
Breaking Medicine Technology:Two UL Battery Safety Standards Are now FDA Recognized Consensus Standards for Medical Devices 2Equashield ernennt Medikus zu seinem exklusiven österreichischen Vertriebspartner für seine geschlossenen Arzneimitteltransfersysteme 2Thoratec Schedules Second Quarter Conference Call, Webcast 2
(Date:7/22/2014)... (PRWEB) July 22, 2014 The Entertainment ... in providing resources, educational tools and recognition activities for ... stories of prevention, treatment and recovery. On July 24, ... will spotlight some of these resources with a special ... Administration helpline and treatment website at the end of ...
(Date:7/22/2014)... 22, 2014 The market for botulinum ... few years, owing to novel medical indications created and ... the aging societies where physical appearance is extremely valued. ... player, current competitors, new companies and technologies are setting ... BoNTs will put the price of 1st-gen products under ...
(Date:7/22/2014)... Kathleen Doheny HealthDay Reporter ... uterus with a minimally invasive procedure known as morcellation carries ... study pinpoints the likelihood more clearly. Twenty-seven of every ... at the time of the procedure, researchers found, with the ... Surgeons performing a hysterectomy with morcellation use a power ...
(Date:7/22/2014)... . Montreal, July ... out for a cigarette twice as often as smokers who ... have the hardest time shaking off the habit may have ... , Those insights were among the collective findings recently published ... a team of researchers based in part at Concordia University. ...
(Date:7/22/2014)... July 22, 2014 5i Sciences, a ... the appointment of Molly Coye, M.D., M.P.H. to a ... internationally renowned authority on the market introduction of innovative ... that she will advise on strategies for building a ... cNEP® technology. Dr. Coye is currently the Chief ...
Breaking Medicine News(10 mins):Health News:ABC’s BLACK BOX Spotlights Mental Health and Available Resources in Upcoming Episode 2Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 2Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 3Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 4Health News:Technique Used in Some Hysterectomies May Help Spread Cancer: Study 2Health News:Technique Used in Some Hysterectomies May Help Spread Cancer: Study 3Health News:Extra exercise helps depressed smokers kick the habit faster 2Health News:5i Sciences Announces Appointment of a Senior Healthcare Consultant and Successful Financing 2
... and parts of Wales. Breast cancer patients from England must ... women get it for free. // ,This discrimination arose ... for Herceptin for early stage breast cancer sufferers until the ... as all Welsh Local Health Boards have agreed to pay ...
... case in the capital of Zagreb it was revealed that a ... bird flu virus. //, ,The location of the dead swan ... last weekend. Tests confirmed that the dead bird had contracted the ... whether it was the lethal H5N1 strain would be released on ...
... observing participants at a simulated investment game, a ... and sustained motivation while working //collectively in a ... ,The study conducted by the University ... of targets among teams, when ‘punishments’ became a ...
... prepared to pledge more money to combat bird flu as ... and Asian donors had pledged $1.9 billion in January, during ... containment and prevention methods in 12 countries, mostly in Asia. ... world through migratory birds, including infections in at least five ...
... and newborns should avoid exposure to the fumes of ... contain dyes and lacquers//, could give rise to allergies ... specialist at Germany's environmental agency. ,Pregnant women ... professionals and stay clear of the work area altogether. ...
... Research Institute has warned the nation's betel-nut chewers of ... other detrimental habits like smoking and drinking. ... at the National Health Research Institute when betel nut ... of developing cancer of the esophagus was about 195 ...
Cached Medicine News:Health News:Free Herceptin Treatment for Those Who Live Over the Welsh Border 2Health News:Motivation Yardstick: Rewards or Punishment? Discover the Superior Performance Trigger 2Health News:Cancer Risks for Betel Nut Chewers 2
... The Techne TC-512 has a graphical touch ... your experiments at the "touch of a ... Wide linear gradient, Touch Screen, Graphical Display, ... Performance, Versatile Block Format, Intuitive Programmin, Free ...
... high performance, high sample throughput instrument at a ... Flexible block format, a newly designed flexible ... Includes a four year or 80,000 Cycle ... be connected and run through a PC using ...
... MyGenie 32 Thermal Block has a compact ... or lower temperatures rapidly, and can handle up to ... the lid, so there is no need to add ... Up to 100 programs can be stored, and up ...
... cycler is the smallest footprint two-bay thermal ... ever before. The Disciple instrument ... communications to a computer using a remote ... thermal cycler contains the latest in power ...
Medicine Products: